Foster & Motley Inc. lifted its stake in Exelon Co. (NYSE:EXC) by 8.6% in the second quarter, HoldingsChannel reports. The firm owned 55,979 shares of the energy giant’s stock after purchasing an additional 4,445 shares during the period. Foster & Motley Inc.’s holdings in Exelon were worth $2,684,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in the stock. AQR Capital Management LLC boosted its position in shares of Exelon by 37.0% in the 1st quarter. AQR Capital Management LLC now owns 24,339,629 shares of the energy giant’s stock valued at $1,216,738,000 after purchasing an additional 6,567,683 shares during the period. Northern Trust Corp boosted its position in shares of Exelon by 7.3% in the 1st quarter. Northern Trust Corp now owns 12,984,265 shares of the energy giant’s stock valued at $650,901,000 after purchasing an additional 887,524 shares during the period. Geode Capital Management LLC boosted its position in shares of Exelon by 8.4% in the 4th quarter. Geode Capital Management LLC now owns 12,839,080 shares of the energy giant’s stock valued at $578,058,000 after purchasing an additional 994,381 shares during the period. Bank of Montreal Can boosted its position in shares of Exelon by 3.3% in the 1st quarter. Bank of Montreal Can now owns 7,962,924 shares of the energy giant’s stock valued at $399,180,000 after purchasing an additional 255,364 shares during the period. Finally, Norges Bank acquired a new position in shares of Exelon in the 4th quarter valued at $319,596,000. Institutional investors and hedge funds own 79.69% of the company’s stock.
EXC has been the subject of a number of recent analyst reports. Barclays reiterated a “top pick” rating and issued a GBX 3,250 ($42.47) price target on shares of in a research report on Wednesday, June 19th. ValuEngine upgraded Worldline from a “hold” rating to a “buy” rating in a research report on Tuesday. Goldman Sachs Group upgraded Exelon from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $48.00 to $52.00 in a research report on Thursday, June 6th. Wells Fargo & Co set a $68.00 price objective on Emergent Biosolutions and gave the stock a “hold” rating in a research report on Tuesday, April 2nd. Finally, Morgan Stanley set a $18.00 price objective on PG&E and gave the stock a “hold” rating in a research report on Friday, June 14th. Eight analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $49.96.
NYSE EXC traded up $0.09 during trading on Friday, reaching $46.22. 1,853,820 shares of the company’s stock were exchanged, compared to its average volume of 5,467,797. Exelon Co. has a fifty-two week low of $41.65 and a fifty-two week high of $51.18. The company has a market capitalization of $44.68 billion, a price-to-earnings ratio of 14.81, a PEG ratio of 4.05 and a beta of 0.37. The company has a quick ratio of 0.89, a current ratio of 1.02 and a debt-to-equity ratio of 0.99. The stock has a fifty day moving average price of $49.00.
Exelon (NYSE:EXC) last announced its quarterly earnings data on Thursday, May 2nd. The energy giant reported $0.87 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.87. The firm had revenue of $9.48 billion during the quarter, compared to analyst estimates of $9.10 billion. Exelon had a return on equity of 8.85% and a net margin of 6.52%. The business’s quarterly revenue was down 2.2% compared to the same quarter last year. During the same period last year, the company posted $0.96 EPS. As a group, sell-side analysts expect that Exelon Co. will post 3.11 earnings per share for the current fiscal year.
In other news, CEO Calvin Butler, Jr. sold 31,000 shares of Exelon stock in a transaction dated Friday, June 28th. The stock was sold at an average price of $47.59, for a total transaction of $1,475,290.00. Following the completion of the sale, the chief executive officer now directly owns 40,331 shares in the company, valued at approximately $1,919,352.29. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Kenneth W. Cornew sold 54,300 shares of Exelon stock in a transaction dated Tuesday, June 18th. The shares were sold at an average price of $49.82, for a total value of $2,705,226.00. Following the sale, the executive vice president now owns 97,813 shares of the company’s stock, valued at $4,873,043.66. The disclosure for this sale can be found here. 0.27% of the stock is owned by insiders.
Exelon Company Profile
Exelon Corporation, a utility services holding company, engages in energy generation and delivery businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services.
Further Reading: Should You Consider an Index Fund?
Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NYSE:EXC).
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.